News
Israeli Cannabis Breakthrough Opens New Hope for Fatty Liver Disease
NEW YORK- A new study out of Israel has put Cannabis back into one of the most important conversations in modern medicine: metabolic disease. Researchers at the Hebrew University of Jerusalem have reported that two non-intoxicating Cannabis compounds, CBD and CBG, significantly reduced liver fat and improved metabolic health in experimental models of fatty liver ...
Why the Endocannabinoid System Is the Future of Cannabis Medicine
NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The deeper opportunity is understanding how Cannabis interacts with one of the body’s most important regulatory networks: the endocannabinoid system. The ...
Cannabis, Inflammation, and the Next Frontier in Root-Cause Medicine
NEW YORK- Cannabis medicine is moving beyond pain, sleep, and anxiety. One of the most important next frontiers may be inflammation, because the endocannabinoid system plays a direct role in how the body regulates immune response, inflammatory signaling, pain, metabolism, and recovery. That matters because chronic inflammation is not just a symptom of disease. It ...
Why Metabolic Dysfunction May Be the Next Frontier for Cannabinoid Medicine
NEW YORK- Metabolism is the system that determines how the body produces, distributes, and uses energy, and it sits at the center of modern chronic disease. While it is often reduced to a discussion of calories or weight, metabolism is fundamentally a cellular process governed by hormonal signaling, mitochondrial function, and nutrient utilization. When it ...
Cresco Labs Reports Q1 2026 Financial Results
CHICAGO – Cresco Labs Inc. released its first-quarter results, showcasing the ongoing efforts of one of the largest MSOs to strengthen operations across its footprint while preparing for potential changes at the federal level. With cultivation improvements and selective market moves in play, the results reflect both near-term pressures common to the sector and steps ...
Cronos Group Reports Q1 2026 Financial Results
TORONTO – Cronos Group Inc. posted record net revenue and gross profit for the first quarter of 2026, driven by higher sales volumes, a favorable product mix, and gains in key markets. The Cannabis company disclosed a sharply positive earnings report, posting first-quarter 2026 net revenue of $45.2 million, a 40% increase year-over-year that beat ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past two weeks brought measurable movement across federal policy, corporate financial reporting, international deals, and product categories in the U.S. Cannabis sector. Operators absorbed details on rescheduling implications, watched hemp-derived THC face tighter constraints, and reviewed strong first-quarter earnings from major players. Psychedelic research added another data point that politicians can ...
Congress Presses FDA on Psychedelic Therapy Approvals
WASHINGTON – A bipartisan coalition of 32 House members sent a formal letter to FDA Commissioner Martin A. Makary urging the agency to move faster on ongoing reviews of psychedelic treatments. The letter stated that "for many individuals, current treatment options remain insufficient, deepening an already urgent public health crisis," and referenced veterans, clinicians, and ...
TerrAscend Reports Q1 2026 Financial Results
TORONTO – TerrAscend Corp. announced financial results for the first quarter ended March 31, 2026, showing modest year-over-year revenue growth from continuing operations and sustained operational performance across its core Northeast markets. The company reported net revenue of $65.5 million, up from $64.3 million in the same period last year but down slightly from $66.1 ...
Trulieve Reports Q1 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first quarter that presents two concurrent narratives – a retail operation contending with sustained pricing pressure, and a company whose federal tax obligations are, for the first time, beginning to reflect a more normalized business reality. The multistate Cannabis operator disclosed Q1 2026 revenue of $286.8 ...
LEEF Brands Reports Q1 2026 Financial Results
VANCOUVER – LEEF Brands Inc. reported its strongest financial quarter since inception, showing marked operational progress and turning what had been a loss position a year ago into meaningful profitability, all without adding a single dollar of new top-line revenue. Revenue for Q1 2026 held steady at $9.4 million, matching the same period in 2025. ...
GTI Reports Q1 2026 Financial Results
CHICAGO – Green Thumb Industries Inc. released its first-quarter 2026 financial results, highlighting steady performance in a market still marked by price competition and variable demand. The multistate Cannabis operator posted steady revenue growth, alongside gains in key profitability measures, solid cash flow from operations, contributions from new store openings, and early impacts from the ...
Target Expands Hemp-Derived THC Beverage Sales Area
NEW YORK – Target is broadening its reach in the hemp-derived THC beverage category, adding the products to more than 300 stores across Florida, Texas and parts of Illinois. The mass retailer confirmed the move as a limited test, building on its earlier pilot in Minnesota. Products will appear in all stores in Florida and ...
Cannara Biotech Wraps Up Medican Organic Acquisition
MONTREAL – Cannara Biotech Inc. announced the closing of a transaction to acquire all of the shares of Medican Organic Inc. for an aggregate purchase price of $2.8 million. On the surface, that's a modest sum. In context, it's the final piece of a five-year consolidation play that Cannara has been assembling since 2021. This ...
Aprio Targets Cannabis Sector in Price Kong Acquisition
ATLANTA-PHOENIX – Aprio, the 20th largest business advisory and accounting firm in the United States, announced it had entered into an agreement to acquire Price Kong, a Phoenix-based CPA and advisory firm. The transaction, effective June 1, 2026, expands Aprio's Arizona presence and brings accounting, audit, and advisory capabilities to complement its existing footprint in ...
RYTHM Reports Q1 2026 Financial Results
ROLLING MEADOWS – RHYTHM Inc. disclosed stronger results for the first quarter of 2026 as the company continued its shift toward branded hemp-derived THC products and licensing deals. Revenue from continuing operations came in at $13.3 million, a 24% jump from $10.7 million the prior quarter, while gross profit reached $10.4 million, representing a 78% ...
High Tide Scores Big in Germany Through Remexian Distribution
CALGARY-BERLIN – High Tide Inc. reported that its majority-owned German subsidiary, Remexian Pharma GmbH, distributed 7.6 tons of medical Cannabis flower into the German market during the second fiscal quarter ended April 30, 2026 – the highest quarterly volume in the company's history since its founding in 2018. Volume increased 21% on a sequential basis ...
Curaleaf Reports Q1 2026 Financial Results
STAMFORD – Curaleaf Holdings Inc. posted its strongest revenue growth in years during the first quarter of 2026, swinging to a net profit just as the federal regulatory environment under which the industry operates began to shift in a specific, measurable way. For Q1 2026, Curaleaf reported net revenue of $324.2 million, up 6% from ...
LeafLink Releases 2026 Wholesale Cannabis Pricing Guide
NEW YORK – LeafLink, a unified B2B marketplace and technology platform built specifically for the Cannabis industry, published its annual 2026 Wholesale Cannabis Pricing Guide, delivering one of the most comprehensive data snapshots the legal Cannabis trade has produced to date. The report draws on billions of dollars in actual transactions and covers more than ...
Psilocybin Shows Promise for Those Ready to Break Free from Nicotine
BALTIMORE – Researchers at Johns Hopkins University have published findings from a pilot randomized clinical trial that points to potential advantages of psilocybin-assisted therapy over standard nicotine replacement for helping adults quit cigarettes. Published in JAMA Network Open, the study compared nicotine patches to psilocybin as smoking cessation tools. At the six-month mark, participants who ...
Hall of Flowers Relocates Northern California Event to Sacramento
LOS ANGELES – After eight years in Santa Rosa, the B2B Cannabis trade show Hall of Flowers is moving its Northern California event to the Cal Expo exhibition halls in Sacramento. The newly confirmed dates, November 4 and 5, 2026, mark the first time the show has ever staged an event in California's state capital. ...
Vireo to Acquire FLUENT in All-Stock Deal
LOS ANGELES – Vireo Growth Inc. announced it has signed a definitive agreement to absorb FLUENT Corp. in an all-stock transaction, a deal that, if approved, would make Vireo the third-largest operator in medical-only Florida's multibillion-dollar Cannabis market. Under the terms of the definitive arrangement agreement, FLUENT shareholders will receive 0.0705359 of a Vireo subordinate ...
DEA Assigns Specific Schedule I Listing and Drug Code to HHC
WASHINGTON – The Drug Enforcement Administration (DEA) has issued a final rule that formally lists hexahydrocannabinol (HHC) as a Schedule I controlled substance with its own dedicated drug code. The notice, published in the Federal Register, establishes the specific entry for the compound 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (HHC) in the list of Schedule I hallucinogenic substances. It assigns ...
Allied Market Research: Global Cannabis Market to Generate $149B by 2031
PORTLAND – A report recently published by Allied Market Research projects the global Cannabis market will reach $148.9 billion by 2031, up from $25.7 billion in 2021 – a nearly sixfold increase over a decade, compounding at 20.1% annually. For the industry that spent most of the 20th century in legal exile, those figures represent ...
Curaleaf Takes Full Control of Germany’s Four 20 Pharma
STAMFORD – Curaleaf Holdings Inc. closed the final chapter of a four-year German acquisition story, completing the buyout of the remaining 45% stake it did not previously own in Four 20 Pharma GmbH, a move that converts a once-minority investment into full corporate ownership. The deal traces back to August 2022, when Curaleaf first announced ...
